Inventor
OLHAVA EDWARD JAMES
US20 patents
⚠️ This page may combine multiple inventors who share the name “OLHAVA EDWARD JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EPIZYME INC
10 patentsUS8962620B2Feb 24, 2015
Substituted 6,5-fused bicyclic heteroaryl compounds
EPIZYME INC31 citations98
US8598167B1Dec 3, 2013
Substituted 6,5-fused bicyclic heteroaryl compounds
EPIZYME INC34 citations96
US9206157B2Dec 8, 2015
Substituted 6,5-fused bicyclic heteroaryl compounds
EPIZYME INC28 citations94
US9637472B2May 2, 2017
Substituted 6,5-fused bicyclic heteroaryl compounds
EPIZYME INC16 citations92
US8722877B2May 13, 2014
7-deazapurine modulators of histone methyltransferase, and methods of use thereof
EPIZYME INC19 citations92
US10968247B2Apr 6, 2021
Methods of synthesizing substituted purine compounds
EPIZYME INC4 citations84
US10273223B2Apr 30, 2019
Substituted 6,5-fused bicyclic heteroaryl compounds
EPIZYME INC5 citations84
US9175032B2Nov 3, 2015
Methods of synthesizing substituted purine compounds
EPIZYME INC6 citations84
US9738679B2Aug 22, 2017
Methods of synthesizing substituted purine compounds
EPIZYME INC2 citations73
US11753433B2Sep 12, 2023
Methods of synthesizing substituted purine compounds
EPIZYME INC0 citations62
INNATE TUMOR IMMUNITY INC
9 patentsUS10556903B2Feb 11, 2020
NLRP3 modulators
INNATE TUMOR IMMUNITY INC12 citations85
US10604542B2Mar 31, 2020
Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
INNATE TUMOR IMMUNITY INC5 citations83
US10533005B2Jan 14, 2020
NLRP3 modulators
INNATE TUMOR IMMUNITY INC9 citations83
US10961270B2Mar 30, 2021
Compounds and compositions for treating conditions associated with sting activity
INNATE TUMOR IMMUNITY INC2 citations72
US12351580B2Jul 8, 2025
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US11827632B2Nov 28, 2023
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US11505571B2Nov 22, 2022
Compounds and compositions for treating conditions associated with sting activity
INNATE TUMOR IMMUNITY INC0 citations62
US11072612B2Jul 27, 2021
NLRP3 modulators
INNATE TUMOR IMMUNITY INC1 citations62
US10723756B2Jul 28, 2020
Cyclic dinucleotides for treating conditions associated with STING activity such as cancer
INNATE TUMOR IMMUNITY INC0 citations51